designed and synthesized a series of 6BrCaQ-Cn-TPP conjugates as a novel class of TRAP1 inhibitors, among which compound 3a exhibited excellent antiproliferative activity in a variety of cancer cell lines, including human leukemia cells K562 (180). This evidence concerns the gene TRAP1 and leukemia.